Hereditary bladder cancer

Scandinavian Journal of Urology and Nephrology

Volumn 42, Issue SUPPL.218, 2008, Pages 110-115

  Kiemeney, Lambertus A L M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bladder cancer; Familial clustering; Hereditary

Indexed keywords

BLADDER CANCER; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CONFERENCE PAPER; FAMILIAL CANCER; GENE CLUSTER; GENE IDENTIFICATION; GENE MAPPING; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; PRIORITY JOURNAL; BLADDER TUMOR; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOTYPE; METHODOLOGY; REVIEW; TUMOR GENE;

GENES, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 52949097296     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/03008880802283755     Document Type: Conference Paper

References (31)

1. Thelen A, Schaeuble J. Gleichzeitiges Vorkommen von BlasenpapiIlomen bei eineiigen ZwiIlingen. Z Urol 1957;50:188-95.
2. Fraumeni JF Jr, Thomas LB. Malignant bladder tumors in a man and his three sons. JAMA 1967;201:507.
3. Benton B, Henderson BE. Environmental exposure and bladder cancer in young males. J Natl Cancer Inst 1973;51:269-70.
4. McCullough DL, Lamm DL, McLaughlin AP III, Gittes RF. Familial urothelial cell carcinoma of the bladder. J Urol 1975;113:629-35.
5. Lynch HT, Walzak MP, Fried R, Domina AH, Lynch JF. Familial factors in bladder carcinoma. J Urol 1979;122:458-61.
6. Mahboubi AO, Ahlvin RC, Mahboubi EO. Familial aggregation of urothelial carcinoma. J Urol 1981;126:691-2.
7. Purtilo DT, McCarthy B, Yang JP, Friedell GH. Familial urinary bladder cancer. Semin Oncol 1979;6:254-6.
8. Aben KK, Macville MV, Smeets DF, Schoenberg MP,Witjes JA, Kiemeney LA. Absence of karyotype abnormalities in patients with familial urothelial cell carcinoma. Urology 2001;57:266-9.
9. Kramer AA, Graham S, Burnett WS, Nasca P. Familial aggregation of bladder cancer stratified by smoking status. Epidemiology 1991;2:145-8.
10. Kiemeney LA, Moret NC, Witjes JA, Schoenberg MP, Tulinius H. Familial urothelial cell carcinoma among the population of Iceland. J Urol 1997;157:1649-51.
11. Aben KK, Witjes JA, Schoenberg MP, Hulsbergen-van de Kaa C, Verbeek AL, Kiemeney LA. Familial aggregation of urothelial cell carcinoma. Int J Cancer 2002;98:274-8.
12. Murta-Nascimento C, Silverman DT, Kogevinas M, Garcia-Closas M, Rothman N, Tardon A, et al. Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol Biomarkers Prev 2007;16:1595-600.
13. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-8.
14. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85.
15. Dong C, Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 2001;92:144-50.
16. Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 2002;99:260-6.
17. Aben KK, Baglietto L, Baffoe-Bonnie A, Coebergh JW, Bailey-Wilson JE, Trink B, et al. Segregation analysis of urothelial cell carcinoma. Eur J Cancer 2006;42:1428-33.
18. Aben KK, Cloos J, Koper NP, Braakhuis BJ, Witjes JA, Kiemeney LA. Mutagen sensitivity in patients with familial and non-familial urothelial cell carcinoma. Int J Cancer 2000;88:493-6.
19. Kiemeney LA, Kuiper RP, Pfundt R, van Reijmersdal S, Schoenberg MP, Aben KK, et al. No evidence for large-scale germline genomic aberrations in hereditary bladder cancer patients with high-resolution array-based comparative genomic hybridization. Cancer Epidemiol Biomarkers Prev 2006;15:180-3.
20. Chan H, Pratt CB. A new familial cancer syndrome? A spectrum of malignant and benign tumors including retinoblastoma, carcinoma of the bladder, and other genitourinary tumors, thyroid adenoma, and a probable case of multifocal osteosarcoma. J Natl Cancer Inst 1977;58:205-7.
21. Aherne G. Retinoblastoma associated with other primary malignant tumours. Trans Opthalmol Soc UK 1974;94:938-44.
22. Tarkkanen A, Karjalainen K. Excess of cancer deaths in close relatives of patients with bilateral retinoblastoma. Ophthalmologica 1984;189:143-6.
23. DerKinderen DJ, Koten JW, Nagelkerke NJ, Tan KE, Beemer FA, Den Otter W. Non-ocular cancer in patients with hereditary retinoblastoma and their relatives. Int J Cancer 1988;41:499-504.
24. Sanders BM, Jay M, Draper GJ, Roberts EM. Non-ocular cancer in relatives of retinoblastoma patients. Br J Cancer 1989;60:358-65.
25. Fletcher O, Easton D, Anderson K, Gilham C, JayM, Peto J. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 2004;96:357-63.
26. Liang SX, Lakshmanan Y, Woda BA, Jiang Z. A high-grade primary leiomyosarcoma of the bladder in a survivor of retinoblastoma. Arch Pathol Lab Med 2001;125:1231-4.
27. Bleoo SL, Godbout R, Rayner D, Tamimi Y, Moore RB. Leiomyosarcoma of the bladder in a retinoblastoma patient. Urol Int 2003;71:118-21.
28. Venkatraman L, Goepel JR, Steele K, Dobbs SP, Lyness RW, McCluggage WG. Soft tissue, pelvic, and urinary bladder leiomyosarcoma as second neoplasm following hereditary retinoblastoma. J Clin Pathol 2003;56:233-6.
29. Guo Z, Linn JF, Wu G, Anzick SL, Eisenberger CF, Halachmi S, et al. CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer. Nat Med 2004;10:374-81.
30. Schoenberg M, Kiemeney L, Walsh PC, Griffin CA, Sidransky D. Germline translocation t(5;20)(p15;q11) and familial urothelial cell carcinoma. J Urol 1996;155:1035-6.
31. Schultz IJ, Kiemeney LA, Witjes JA, Schalken JA, Willems JL, Swinkels DW, et al. CDC91L1 (PIG-U) mRNA expression in urothelial cell carcinomas. Int J Cancer 2005;116:282-4.